# Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs

> **NCT00192803** · PHASE4 · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 20 (—)

## Conditions studied

- NIDDM

## Interventions

- **DRUG:** candesartan

## Key facts

- **NCT ID:** NCT00192803
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192803, "Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00192803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
